Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Blood
|
April 25, 2009
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation
Stephan Metzelder, Ying Wang, Ellen Wollmer, et al.
Molecular Cell
|
November 1, 2002
Negative regulation of the mammalian UV response by Myc through association with Miz-1
Steffi Herold, Michael Wanzel, Vincent Beuger, et al.
The Journal of Cell Biology
|
March 24, 2010
The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis
Barbara Herkert, Anne Dwertmann, Steffi Herold, et al.
Translational Gastroenterology and Hepatology
|
February 12, 2026
Leptin-dependent fat accumulation triggers autophagy in metabolic dysfunction-associated steatohepatitis model
Sophia C H Polte, Tomomitsu Matono, Kinya Okamoto, et al.
Nucleic Acids Research
|
January 29, 2016
ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma
Anne Catherine Bretz, Miriam P Gittler, Joël P Charles, et al.
Nature Communications
|
June 4, 2014
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
Joël P Charles, Jeannette Fuchs, Mirjam Hefter, et al.
Nature Communications
|
September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
BMC Cancer
|
July 19, 2022
The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Robert Mandic, André Marquardt, Philip Terhorst, et al.
The EMBO Journal
|
September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
The EMBO Journal
|
March 25, 2026
Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Blood
|
April 25, 2009
Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation
Stephan Metzelder, Ying Wang, Ellen Wollmer, et al.
Molecular Cell
|
November 1, 2002
Negative regulation of the mammalian UV response by Myc through association with Miz-1
Steffi Herold, Michael Wanzel, Vincent Beuger, et al.
The Journal of Cell Biology
|
March 24, 2010
The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis
Barbara Herkert, Anne Dwertmann, Steffi Herold, et al.
Translational Gastroenterology and Hepatology
|
February 12, 2026
Leptin-dependent fat accumulation triggers autophagy in metabolic dysfunction-associated steatohepatitis model
Sophia C H Polte, Tomomitsu Matono, Kinya Okamoto, et al.
Nucleic Acids Research
|
January 29, 2016
ΔNp63 activates the Fanconi anemia DNA repair pathway and limits the efficacy of cisplatin treatment in squamous cell carcinoma
Anne Catherine Bretz, Miriam P Gittler, Joël P Charles, et al.
Nature Communications
|
June 4, 2014
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
Joël P Charles, Jeannette Fuchs, Mirjam Hefter, et al.
Nature Communications
|
September 18, 2020
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
BMC Cancer
|
July 19, 2022
The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC
Robert Mandic, André Marquardt, Philip Terhorst, et al.
The EMBO Journal
|
September 5, 2019
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
The EMBO Journal
|
March 25, 2026
Author Correction: Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Oleg Timofeev, Boris Klimovich, Jean Schneikert, et al.
Page
of 3